Revolutionising Surgery Scheduling: an innovative AI-powered health-tech platform enhancing Operating Room efficiency, with an automated schedule unlocking the potential for an additional 10% or 350K surgeries annually in the UK.

彻底改变%20手术%20调度：%20an%20创新%20AI驱动%20健康科技%20平台%20增强%20操作%20房间%20效率，%20与%20an%20自动化%20调度%20解锁%20%20潜力%20用于%20an%20额外%

• 批准号: 10095646
• 金额: $ 25.99万
• 依托单位: OPALFLOW LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2024
• 资助国家: 英国
• 起止时间: 2024 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10095646
• 关键词: Revolutionising; Surgery; Scheduling; innovative; AI

OpalFlow is a UK-based digital health SME with a core project team of Natalie Cooke CEO (Registered Nurse/MSc International Healthcare Management) and Radovan Vitek CTO (full-stack developer/MSc Software Engineering).The UK's extensive waiting list for elective surgeries, which exceeds 7 million people, particularly impacts patients awaiting hip and knee replacements and cancer treatments. These individuals experience deteriorating conditions that have a negative impact on their mental and physical well-being. For cancer patients, even a four-week delay in receiving surgery increases the risk of mortality by 6-8%. Additionally, the underutilisation of Operating Rooms (ORs) results in a missed opportunity for approximately 350,000 surgeries annually, further prolonging waiting lists and undermining public confidence in the system.OpalFlow aims to address these challenges by developing a comprehensive AI-based web and mobile app for OR scheduling. The platform automates all aspects of managing OR capacity with the potential to increase the number of surgeries by up to 10%.The project's primary focus will be on patients waiting for hip and knee replacements, especially those experiencing severe chronic pain. The Midlands, with the longest waiting list for hip and knee replacements in the UK (<150,000 people), will benefit significantly from OpalFlow's efforts to increase the number of surgeries in this region.This initiative aligns directly with the NHS Delivery plan, addressing the backlog of elective care resulting from the COVID-19 pandemic. The plan outlines clear goals for the recovery of elective services over the next three years, making OpalFlow's project opportune and valuable in supporting the plan's objectives.

OpalFlow 是一家总部位于英国的数字健康中小企业，其核心项目团队由 Natalie Cooke 首席执行官（注册护士/国际医疗管理理学硕士）和 Radovan Vitek 首席技术官（全栈开发人员/软件工程理学硕士）组成。英国有大量择期手术的等候名单超过 700 万人，尤其影响等待髋关节和膝关节置换术以及癌症治疗的患者。这些人的病情不断恶化，对他们的身心健康产生负面影响。对于癌症患者来说，即使推迟 4 周接受手术，死亡风险也会增加 6-8%。此外，手术室 (OR) 的利用率不足导致每年约 350,000 例手术错失良机，进一步延长了等候名单并削弱了公众对该系统的信心。OpalFlow 旨在通过开发基于人工智能的综合网络和移动应用程序来应对这些挑战用于手术室调度。该平台可自动化管理手术室容量的各个方面，有可能将手术数量增加多达 10%。该项目的主要重点将是等待髋关节和膝关节置换术的患者，特别是那些经历严重慢性疼痛的患者。中部地区是英国髋关节和膝关节置换术等待名单最长的地区（<150,000 人），该地区将从 OpalFlow 增加该地区手术数量的努力中受益匪浅。该举措与 NHS 交付计划直接一致，解决了COVID-19 大流行导致选择性护理积压。该计划概述了未来三年恢复选择性服务的明确目标，使 OpalFlow 的项目在支持该计划目标方面恰逢其时且有价值。